ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · IEX Real-Time Price · USD
0.253
+0.010 (4.21%)
Apr 26, 2024, 3:57 PM EDT - Market closed
ENDRA Life Sciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for ENDRA Life Sciences.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for NDRA.
Recommendation Trends
| Rating | Feb '23 | Mar '23 |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 → $9 | Strong Buy | Reiterates | $100 → $9 | +3,464.36% | Mar 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $120 → $100 | Strong Buy | Maintains | $120 → $100 | +39,503.96% | Apr 7, 2022 |
Financial Forecast
Revenue This Year
1.02M
Revenue Next Year
n/a
from 1.02M
EPS This Year
-1.44
from -1.58
EPS Next Year
n/a
from -1.44
Revenue Forecast
| Revenue | 2024 |
|---|---|
| High | 1.1M |
| Avg | 1.0M |
| Low | 980,000 |
Revenue Growth
| Revenue Growth | 2024 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
EPS Forecast
| EPS | 2024 |
|---|---|
| High | -1.48 |
| Avg | -1.44 |
| Low | -1.38 |
EPS Growth
| EPS Growth | 2024 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.